newsletter subscription
email
Company Profiles
Pfizer
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Website: www.pfizer.com
Facebook: www.facebook.com/Pfizer
Krystal Biotech Switzerland GmbH
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs.
VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa.
The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania.
Website: www.krystalbio.com
Viatris
Viatris Inc. is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. From cardiovascular health to dermatology, Viatris offers quality treatment options across more than 10 major therapeutic areas, covering a wide variety of noncommunicable and infectious diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India.
Website: www.viatris.com
Ceramol (Unifarco)
Ceramol is an Italian dermatological brand developed by Unifarco, headquartered in the Belluno Dolomites, where it has been operating since 1982.
For over 30 years, Ceramol has been committed to providing targeted solutions for skin disorders, with the aim of improving patients’ quality of life.
The skin barrier is at the core of our research.
Through close collaboration with dermatologists, academic researchers, and pharmacists, Ceramol develops advanced solutions for atopic dermatitis, allergic and reactive skin, besides psoriasis and acne.
Our in-depth understanding of skin physiology and its alterations has led us to adopt the following fundamental principle: to provide the skin with only what it strictly needs to ensure high tolerability and efficacy.
Ceramol products are formulated to be suitable for even the most delicate skin, including that of infants and children.
A key innovation of the brand is the 311 Technology, based on the combination of the three essential epidermal lipids—ceramides, cholesterol, and fatty acids—in the optimal 3:1:1 ratio. Delivered through an advanced carrier system, this technology helps restore the skin barrier and maintain its physiological function.
Website: www.ceramol.it
Facebook: www.facebook.com/ceramol.dermocosmetics
Galderma Italy
Galderma is a global leader in dermatology, committed to providing innovative medical solutions to meet people's needs throughout their lives, while also supporting healthcare professionals around the world.
Galderma continues to invest in innovation with the aim of offering advanced technologies and services in the three segments in which it operates. For example, in recent years, one of Galderma's priorities has been the development of innovative therapies for atopic dermatitis and prurigo nodularis.
Website: www.galderma.com/italy
General Topics SRL
General Topics researches, develops and manufactures cosmetic products, food supplements and medical devices for topical use in the fields of dermatology, aesthetic medicine and cosmetology.
Over the past 30 years, the company has dedicated its passion and energies to finding effective and safe solutions for various skin conditions and diseases.
Nowadays, the General Topics products are sold in more than 40 countries all over the world.
General Topics is open towards a scientific and technological future where knowledge is conceived as limitless, with infinite possibility of evolution. We believe that THE FUTURE IS OPEN
Chiesi Italia Spa
Chiesi is an international, research oriented biopharmaceutical group committed to developing innovative therapies in respiratory care, rare diseases, and specialty care. A Benefit Corporation in several countries and a certified B Corp since 2019, Chiesi promotes shared value and environmental responsibility. Headquartered in Parma, it has 31 affiliates, over 7,500 employees, and global research hubs.
Chiesi Italy, the Gro’p’s Italian affiliate, focuses on medical scientific information and the commercialization of products across the Italian market. Its 461 employees support healthcare professionals nationwide, with teams based at the Parma headquarters and active throughout the country.
Website: www.chiesi.it
ALMIRALL S.P.A.
Almirall è un’azienda biofarmaceutica globale, fondata a Barcellona oltre 80 anni fa e oggi presente in più di 100 Paesi. Completamente dedicata alla dermatologia medica, sviluppa soluzioni innovative per migliorare la qualità di vita delle persone con patologie cutanee. Con oltre 2.000 dipendenti e una forte rete di collaborazioni accademiche e cliniche, Almirall unisce ricerca scientifica avanzata e attenzione ai bisogni emotivi e sociali dei pazienti. L’azienda promuove un approccio olistico alla cura dermatologica, integrando sostenibilità, responsabilità e impatto positivo sulla società.
Website: www.almirall.com
Beiersdorf SpA
Eucerin®, the pharmacy division of Beiersdorf, has been dedicated to skin science for over 100 years and is present in more than 70 countries worldwide.
As pioneer and inventor of modern skincare, Eucerin® is constantly searching for scientific innovations and committed to develop effective, highly tolerable, and clinically tested solutions.
With more than 1,500 active patents, Eucerin’s products are developed to support and enhance the health and beauty of the skin.
With tangible and visible results Eucerin’s products can solve skin problems and help improve consumers' daily well-being and quality of life.
Laboratoires Dermatologiques D'Uriage Italia Srl
Laboratoires Dermatologiques d’Uriage Italia Srl represents the Italian branch of Uriage, a leading French dermatological skincare brand. Founded on the therapeutic properties of Uriage Thermal Water, the company develops high‑quality, science‑based skincare products designed to support dermatologists and meet diverse patient needs. Its portfolio includes targeted solutions for sensitive, dry, acne‑prone, and atopic skin, combining dermatological expertise with innovative formulations. Uriage Italia collaborates closely with healthcare professionals to promote safe, effective skincare and improve patient well‑being.
RHEACELL GmbH & Co. KG
We are a leading, clinically advanced biopharmaceutical stem cell company with more than 20 years of experience, dedicated to drug development (proprietary cell therapeutics that are currently in late-stage clinical trials) based on ABCB5+ MSCs as a platform technology. Our focus is on the development of innovative stem cell therapies (ATMP in accordance with Section 13 of the German Medicines Act) for patients suffering from severe immune- and inflammation-related diseases with high unmet medical need – particularly in the field of rare diseases. Our goal is to establish new therapeutic standards where satisfactory treatment options have not yet been available.
Website: www.rheacell.com/
ESPD OFFICE
domain
Address for official postal correspondence:
ESPD Office
c/o C-IN
5. kvetna 65, Prague Congress Centre
140 21 Prague 4
Czech Republic
Registered at:
1 Place de l'Hôpital
670 91 Strasbourg CEDEX
France
mail_outline
Office email address
office@espd.info
Copyright © 2022 European Society for Pediatric Dermatology
Powered by APPTIDE | Created by C-IN | Privacy Policy